日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancer.

RAD51 同源重组缺陷与早期乳腺癌的治疗反应和生存率相关。

期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-026-00920-5
Llop-Guevara Alba, Pellegrino Benedetta, Pimentel Isabel, Villacampa Guillermo, Solinas Cinzia, Torres-Esquius Sara, Campanini Nicoletta, Simonetti Sara, Tommasi Chiara, Serra Olga, Corianò Matilde, Boggiani Daniela, Michiara Maria, Minari Roberta, Bortesi Beatrice, Rapacchi Elena, Dieci Maria Vittoria, Lambertini Matteo, Zoppoli Gabriele, Schirone Alessio, Casarini Chiara, Cretella Elisabetta, Cortesi Laura, Silini Enrico Maria, Saura Cristina, Willard-Gallo Karen, Boisson Anais, Musolino Antonino, Serra Violeta, Balmaña Judith, Cruz Cristina
乳腺癌
肿瘤
RAD51
发表日期：2026
文献求助 收藏

Coronary Computed Tomographic Angiography to Optimize the Diagnostic Yield of Invasive Angiography for Low-Risk Patients Screened With Artificial Intelligence: Protocol for the CarDIA-AI Randomized Controlled Trial

利用人工智能筛查低风险患者，通过冠状动脉计算机断层扫描血管造影术优化介入血管造影的诊断率：CarDIA-AI随机对照试验方案

期刊:JMIR Research Protocols
影响因子:1.5
doi:10.2196/71726
Petch, Jeremy; Tabja Bortesi, Juan Pablo; Sheth, Tej; Natarajan, Madhu; Pinilla-Echeverri, Natalia; Di, Shuang; Bangdiwala, Shrikant I; Mosleh, Karen; Ibrahim, Omar; Bainey, Kevin R; Dobranowski, Julian; Becerra, Maria P; Sonier, Katie; Schwalm, Jon-David
发表日期：2025
文献求助 收藏

Functional HRD by RAD51 identifies BRCA1 VUS associated with loss of gene function and response to DNA-damaging agents

RAD51 的功能性 HRD 可识别与基因功能丧失和对 DNA 损伤剂的反应相关的 BRCA1 VUS。

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2024.103629
Casartelli, C; Tommasi, C; Lazzarin, A; Corianò, M; Tornali, C; Serra, O; Campanini, N; Gutiérrez-Enríquez, S; Sikokis, A; Zanoni, D; Minari, R; Bortesi, B; Michiara, M; Boggiani, D; Uliana, V; Llop-Guevara, A; Serra, V; Musolino, A; Pellegrino, B
BRCA1
RAD51
发表日期：2024
文献求助 收藏

Machine Learning Approaches for the Image-Based Identification of Surgical Wound Infections: Scoping Review

基于图像的手术伤口感染识别的机器学习方法：范围综述

期刊:Journal of Medical Internet Research
影响因子:6
doi:10.2196/52880
Tabja Bortesi, Juan Pablo; Ranisau, Jonathan; Di, Shuang; McGillion, Michael; Rosella, Laura; Johnson, Alistair; Devereaux, P J; Petch, Jeremy
炎症/感染
发表日期：2024
文献求助 收藏

Phenotypic Expansion of Autosomal Dominant LZTR1-Related Disorders with Special Emphasis on Adult-Onset Features

常染色体显性遗传LZTR1相关疾病的表型扩展，尤其关注成人发病特征

期刊:Genes
影响因子:2.8
doi:10.3390/genes15070916
Uliana, Vera; Ambrosini, Enrico; Taiani, Antonietta; Cesarini, Sofia; Cannizzaro, Ilenia Rita; Negrotti, Anna; Serra, Walter; Quintavalle, Gabriele; Micale, Lucia; Fusco, Carmela; Castori, Marco; Martorana, Davide; Bortesi, Beatrice; Belli, Laura; Percesepe, Antonio; Pisani, Francesco; Barili, Valeria
LZTR1
发表日期：2024
文献求助 收藏

Genetic Basis of Breast and Ovarian Cancer: Approaches and Lessons Learnt from Three Decades of Inherited Predisposition Testing

乳腺癌和卵巢癌的遗传基础：三十年来遗传易感性检测的方法和经验教训

期刊:Genes
影响因子:2.8
doi:10.3390/genes15020219
Barili, Valeria; Ambrosini, Enrico; Bortesi, Beatrice; Minari, Roberta; De Sensi, Erika; Cannizzaro, Ilenia Rita; Taiani, Antonietta; Michiara, Maria; Sikokis, Angelica; Boggiani, Daniela; Tommasi, Chiara; Serra, Olga; Bonatti, Francesco; Adorni, Alessia; Luberto, Anita; Caggiati, Patrizia; Martorana, Davide; Uliana, Vera; Percesepe, Antonio; Musolino, Antonino; Pellegrino, Benedetta
肿瘤
肿瘤免疫
乳腺癌
卵巢癌
发表日期：2024
文献求助 收藏

Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer

生殖系BRCA突变在HER2阳性乳腺癌患者中的预后意义

期刊:Breast
影响因子:7.9
doi:10.1016/j.breast.2022.07.012
Viansone, A; Pellegrino, B; Omarini, C; Pistelli, M; Boggiani, D; Sikokis, A; Uliana, V; Zanoni, D; Tommasi, C; Bortesi, B; Bonatti, F; Piacentini, F; Cortesi, L; Camisa, R; Sgargi, P; Michiara, M; Musolino, A
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏

Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)

一项评估艾立布林联合吉西他滨治疗局部晚期或转移性三阴性乳腺癌患者的II期临床研究（ERIGE试验）。临床和药物遗传学结果由意大利临床肿瘤研究组（GOIRC）提供。

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2020.100019
Pellegrino, B; Cavanna, L; Boggiani, D; Zamagni, C; Frassoldati, A; Schirone, A; Caldara, A; Rocca, A; Gori, S; Piacentini, F; Berardi, R; Brandes, A A; Foglietta, J; Villa, F; Todeschini, R; Tognetto, M; Naldi, N; Bortesi, B; Montemurro, F; Ardizzoni, A; Boni, L; Musolino, A
肿瘤
IGE
乳腺癌
肿瘤免疫
发表日期：2021
文献求助 收藏

Targeted genome editing of plants and plant cells for biomanufacturing

利用靶向基因组编辑技术对植物和植物细胞进行生物制造

期刊:Transgenic Research
影响因子:2
doi:10.1007/s11248-021-00236-z
Buyel, J F; Stöger, E; Bortesi, L
细胞生物学
发表日期：2021
文献求助 收藏

CRISPR/Cas9-mediated knockout of six glycosyltransferase genes in Nicotiana benthamiana for the production of recombinant proteins lacking β-1,2-xylose and core α-1,3-fucose

利用 CRISPR/Cas9 介导敲除本氏烟中的六个糖基转移酶基因，产生缺乏 β-1,2-木糖和核心 α-1,3-岩藻糖的重组蛋白

期刊:Plant Biotechnology Journal
影响因子:10.1
doi:10.1111/pbi.12981
Julia Jansing, Markus Sack, Sruthy Maria Augustine, Rainer Fischer, Luisa Bortesi
发表日期：2019
文献求助 收藏